News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Gemmus Pharma Closes $3.3M Series B Funding To Develop Superior Flu Drug



5/13/2014 8:06:30 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN FRANCISCO--(BUSINESS WIRE)--Gemmus Pharma Inc. a privately held biotechnology company developing an improved host-targeted treatment for flu, today announced that it has closed on a Series B funding. The funding will be used to complete production and toxicology studies for an IND filing by the end of the year.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES